12/05/2026
A year driven by stronger brands, strategic expansion, and consistent ex*****on excellence.
CORONA Remedies delivered a strong FY26 performance with 17.3% YoY revenue growth and 33.4% YoY growth in PAT.
Find the detailed Q4 & FY26 performance here:
https://www.coronaremedies.com/financials/